Glenmark Pharmaceuticals, US (Glenmark) has been granted final approval by the United States Food and Drug Administration (US FDA) for Calcipotriene cream, 0.005 per cent, the therapeutic equivalent of Dovonex cream, 0.005 per cent of Leo Pharma A/S.
Glenmark plans to commence shipping of Calcipotriene cream, 0.005 per cent immediately.